France Raises More Questions About AstraZeneca Jab Safety As Oxford Releases New Data | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

France Raises More Questions About AstraZeneca Jab Safety As Oxford Releases New Data

The latest update on the AstraZeneca-Oxford COVID jab was released Tuesday afternoon in a report from the University which offered more insight on exactly when vaccine-induced immunity begins, and how effective the vaccine can be after its first dose and after its second.

Unsurprisingly, the data offer a more optimistic read than the batch released by AZ and Oxford the first time around.

But they also suggest that the vaccine is actually more effective overall if doctors wait roughly 3 months before inoculating patients with the second dose, which provides support for "current policy" in the UK.

However, in the US, the FDA-recommended vaccination dosing schedule is 21 days, which has endured despite logistical problems and other issues that have caused delivery delays in NYC and elsewhere (so much for the consistency of the "science"), And the new AstraZeneca vaccine might be able to fix all that.

According to the research team, the first dose alone offers 76% protection from symptomatic COVID 22 days post-vaccination. But the jab successfully offers sustained protection through a 3-month period, even without receiving the second dose, a data point that has already been transformed into a marketing opportunity by AstraZeneca.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA